Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PEG-3, a nontransforming cancer progression gene, is a positive regulator of cancer aggressiveness and angiogenesis.

Proceedings of the National Academy of Sciences of the United States of America - 21 Dec 1999

Su Z Z, Goldstein N I, Jiang H, Wang M N, Duigou G J, Young C S, Fisher P B

Abstract excerpt

Cancer is a progressive disease culminating in acquisition of metastatic potential by a subset of evolving tumor cells. Generation of an adequate blood supply in tumors by production of new blood vessels, angiogenesis, is a defining element in this process. Although extensively investigated, the precise molecular events underlying tumor development, cancer progression, and angiogenesis remain unclear. Subtraction...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Differentiation
Share to Endothelial Growth Factors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphokines

Share to Mice, Nude

Share to Neovascularization, Pathologic

Share to Protein Phosphatase 1

Share to Vascular Endothelial Growth Factor A

Share to Vascular Endothelial Growth Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 10611347
DOI: 10.1073/pnas.96.26.15115
PMCID: PMC24782

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PEG-3, a nontransforming cancer progression gene, is a positive regulator of cancer aggressiveness and angiogenesis.PMID 10611347Read ↗

Subtraction hybridization identifies a transformation progression-associated gene <i>PEG</i> -3 with sequence homology to a growth arrest and DNA damage-inducible geneSemantic proximity Read ↗

Cooperation between AP1 and PEA3 sites within the progression elevated gene-3 (PEG-3) promoter regulate basal and differential expression of PEG-3 during progression of the oncogenic phenotype in transformed rat embryo cells.Semantic proximity Read ↗

PEA3 sites within the progression elevated gene-3 (PEG-3) promoter and mitogen-activated protein kinase contribute to differential PEG-3 expression in Ha-ras and v-raf oncogene transformed rat embryo cells.Semantic proximity Read ↗

E2F1 promotes angiogenesis through the VEGF-C/VEGFR-3 axis in a feedback loop for cooperative induction of PDGF-BSemantic proximity Read ↗

Blood outgrowth endothelial cell-based systemic delivery of antiangiogenic gene therapy for solid tumors.Semantic proximity Read ↗

A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype.Semantic proximity Read ↗

Construction of a novel constitutively active chimeric EGFR to identify new targets for therapy.Semantic proximity Read ↗

Experimental anti‐angiogenesis causes upregulation of genes associated with poor survival in glioblastomaSemantic proximity Read ↗

Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-β signaling in ErbB2/Neu-induced tumors from transgenic miceSemantic proximity Read ↗

Inhibition of angiogenesis and the angiogenesis/invasion shiftSemantic proximity Read ↗

Human Pituitary Tumor-Transforming Gene Induces AngiogenesisSemantic proximity Read ↗

Progress in antiangiogenic gene therapy of cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.